Jefferies Group LLC Galapagos Nv Call Options Transaction History

Jefferies Group LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2020 Nov 13, 2020	SELL	$122.47 - $213.56 $4.29 Million - $7.47 Million	-35,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$185.52 - $231.25 $9.28 Million - $11.6 Million	-50,000 Reduced 58.82%	35,000 $6.91 Million
Q1 2020 May 15, 2020	BUY	$143.0 - $274.03 $12.2 Million - $23.3 Million	85,000 New	85,000 $16.7 Million
Q2 2019 Aug 14, 2019	SELL	$111.45 - $128.93 $20.6 Million - $23.9 Million	-185,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$89.61 - $117.78 $16.6 Million - $21.8 Million	185,000 New	185,000 $21.8 Million
Q4 2018 Feb 14, 2019	SELL	$87.81 - $110.65 $122,934 - $154,910	-1,400 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$90.63 - $120.22 $126,882 - $168,308	1,400 New	1,400 $157,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.58B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.